Jiang Zhong Pharmaceutical Co.,Ltd

SHSE:600750 Stock Report

Market Cap: CN¥14.0b

Jiang Zhong PharmaceuticalLtd Future Growth

Future criteria checks 3/6

Jiang Zhong PharmaceuticalLtd is forecast to grow earnings and revenue by 12.8% and 13.8% per annum respectively. EPS is expected to grow by 13% per annum. Return on equity is forecast to be 23.9% in 3 years.

Key information

12.8%

Earnings growth rate

13.0%

EPS growth rate

Pharmaceuticals earnings growth18.3%
Revenue growth rate13.8%
Future return on equity23.9%
Analyst coverage

Low

Last updated03 Jun 2024

Recent future growth updates

Recent updates

A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)

May 22
A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)

Why Investors Shouldn't Be Surprised By Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E

Apr 15
Why Investors Shouldn't Be Surprised By Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E

Earnings and Revenue Growth Forecasts

SHSE:600750 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,3111,0389251,2624
12/31/20255,5959287801,0624
12/31/20244,9898033607652
3/31/20244,2737338381,044N/A
12/31/20234,3907088271,036N/A
9/30/20234,1796858751,150N/A
6/30/20234,3106557721,086N/A
3/31/20234,2996577601,116N/A
12/31/20223,8855986761,022N/A
9/30/20223,811559595910N/A
6/30/20223,5095918291,101N/A
3/31/20223,127530608834N/A
12/31/20212,874506729917N/A
9/30/20212,644528326500N/A
6/30/20212,549510206357N/A
3/31/20212,594502507660N/A
12/31/20202,441474570753N/A
9/30/20202,481480597714N/A
6/30/20202,467482749858N/A
3/31/20202,437468627714N/A
12/31/20192,449464565641N/A
9/30/20192,167498661753N/A
6/30/20192,001494628739N/A
3/31/20191,832481354463N/A
12/31/20181,755470365486N/A
9/30/20181,731450280402N/A
6/30/20181,764436160313N/A
3/31/20181,77842595293N/A
12/31/20171,747418N/A173N/A
9/30/20171,764438N/A263N/A
6/30/20171,555386N/A396N/A
3/31/20171,497374N/A568N/A
12/31/20161,548372N/A698N/A
9/30/20161,805401N/A659N/A
6/30/20162,150424N/A619N/A
3/31/20162,455411N/A534N/A
12/31/20152,597367N/A511N/A
9/30/20152,664332N/A510N/A
6/30/20152,763308N/A512N/A
3/31/20152,757275N/A438N/A
12/31/20142,834265N/A357N/A
9/30/20142,952188N/A294N/A
6/30/20142,872154N/A245N/A
3/31/20142,829142N/A77N/A
12/31/20132,778172N/A112N/A
9/30/20132,893215N/A87N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600750's forecast earnings growth (12.8% per year) is above the savings rate (2.9%).

Earnings vs Market: 600750's earnings (12.8% per year) are forecast to grow slower than the CN market (22.2% per year).

High Growth Earnings: 600750's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600750's revenue (13.8% per year) is forecast to grow faster than the CN market (13.7% per year).

High Growth Revenue: 600750's revenue (13.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 600750's Return on Equity is forecast to be high in 3 years time (23.9%)


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.